Clinical studies D'Andrea et al.
Oral pharyngeal mucositis: nursing assessment on the efficacy of a new treatment
  • The D'Andrea study, performed on 53 patients receiving therapy for cancer, showed that Gelclair® is an effective intervention in terms of improvements in pain, functionality, and grade of mucositis.  

Graf DAndrea.jpg

  • Gelclair® can reduce 1 grade of the grade of mucositis after only 3 days of treatment. 
  • Gelclair® improves patients' quality of life reducing the difficulty in eating and drinking.

 

Reference:
D'Andrea et al, Annals of Oncology 2003; 14 (suppl. 4):97 (abs 2).

Back
HELSINN This website is for Ex U.S. residents only Last Update: 17.12.2013
Sitemap Privacy Policy Terms of Use